CHASE NEWBY: Open Payments
NPI 1639825060 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,753 in 91 payments from 16 companies in 2025. Trend: 2023 $540 · 2024 $1,933 · 2025 $3,753
Food & beverage: $2,815Travel & lodging: $938
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 30 | $2,398 |
| Novartis Pharmaceuticals Corporation | 18 | $234 |
| Merck Sharp & Dohme LLC | 8 | $181 |
| HEARTFLOW, INC. | 4 | $154 |
| E.R. Squibb & Sons, L.L.C. | 3 | $117 |
| BridgeBio Pharma, Inc. | 3 | $87 |
| Novo Nordisk Inc | 5 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| ABIOMED | 2 | $66 |
| PFIZER INC. | 3 | $63 |
Products named: COREVALVE EVOLUT R, LEQVIO, VERQUVO, FFRct, ELIQUIS, Attruby, JARDIANCE, Wegovy.
Industry payments across TX — which companies pay providers there.
